Login / Signup

Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial.

Chengxiang GuoJunlei ZhangXin HuangYiwen ChenJianpeng ShengXing HuangJun-Hui SunWen-Bo XiaoKe SunShunliang GaoRisheng QueYan ShenMin ZhangJian WuXue-Li BaiJianpeng Sheng
Published in: Hepatology communications (2023)
Sintilimab plus DEB-TACE before surgery showed good efficacy and safety in patients with HCC of BCLC stage A exceeding the Milan criteria or BCLC stage B.
Keyphrases
  • minimally invasive
  • radiofrequency ablation
  • coronary artery bypass
  • patients undergoing
  • open label
  • clinical trial
  • liver metastases
  • acute coronary syndrome
  • percutaneous coronary intervention